ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
REKAMBYS 900 mg / 3 ml, Depot-Injektionssuspension - 
67742002 Janssen-Cilag AG
REKAMBYS 900 mg / 3 ml, Depot-Injektionssuspension08.10.2021
  08.10.2021
Rilpivirine (J05AG05) 
WHO-DDD07.10.2026
08.03. 
08.03. 
A  
Yes 
IP 
551.43Yes
    
10 %616.15
7680677420023Synthetika
  
Composition
rilpivirinum 900 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 3 ml corresp. natrium 2.49 mg.
Packungsbestandteile
Depot-Injektionssuspension 
  
 
Active AgentDose
Rilpivirinum900mg / 3ml
BAG: Active AgentDose
Rilpivirinum900 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Glucose Monohydrate 
Sodium Dihydrogenophosphate Monohydrate 
Sodium Hydroxide 
Poloxamer338
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home